Sagimet Biosciences' Leap Forward: An Oral Presentation on Denifanstat Phase 2b Study data at EASL International Liver Congress 2024: $SGMT Sagimet Biosciences Inc., a California-based… dlvr.it/T6Y0t6 #ClinicalStudy #competitors #SGMT #MajorPharmaceuticalPreparations
Unleashing the Power of CRISPR: Innovations in Glaucoma Treatment and a Vision for the Future: $CRSP Gene editing technologies like CRISPR (Clustered Regularly Interspaced Short Palindromic… dlvr.it/T6bHyZ #ClinicalStudy #suppliers #News #CRSP #CrisprTherapeuticsAg
Alterity Therapeutics' Promising Phase 2 Trial for ATH434 in Multiple System Atrophy Continues as Planned, Bolstering Hope for Novel Treatment Options for Neurodegenerative Disorders.:… dlvr.it/T6bM82 #ClinicalStudy #MultipleSystemAtrophy #AlterityTherapeuticsLimited
Investor Presentation - May 2024: investi.com.au/api/announceme…
'Rett Syndrome Clinical Trial Results'
International Rett Syndrome Foundation #RettSynderome #Retts #NTI #Neurotech #ClinicalTrial #NTI 164 #PediatricNeurology #ClinicalStudy #NeurodevelopmentalDisorders #Neuroscience #ChildHealth …
Advancements in Gene Editing: PM359 Holds Promise in Correcting Chronic Granulomatous Disease Mutation: $PRME Chronic Granulomatous Disease (CGD) is a rare genetic disorder that affects the innate immune system,… dlvr.it/T6bXX0 #customers #News #PRME #ClinicalStudy
Context Therapeutics Bags US FDA Nod of IND Application
News: goo.su/sYmCXj
Martin Lehr, CEO, Context Therapeutics
#biopharmaceuticalfirm #clinicaltrial #clinicalstudy #programmemilestones
Early engagement is crucial for successful execution of a clinical supply plan
#drugdiscovery #drugdevelopment #studystartup #clinicaltrial s #healthcare #clinicalresearch #patientrecruitment #sitemanagement #clinicaldevelopment #clinicaltrial #clinicaloperations #clinicalstudy
“Collecting data outside the traditional confines of the #ClinicalStudy or health system can be very helpful in determining how these drugs, devices and tools really do impact health.” - Andrew Trister, Verily Chief Medical and Science Officer at Milken Institute #MIGlobal today
CytomX Therapeutics: Pioneering a Safer Future in Cancer Treatment with Probody T-cell Engagers: $CTMX CSIMarket.com reports significant advancement in cancer therapeutics with CytomX Therapeutics… dlvr.it/T6cVJQ #ClinicalStudy #CytomxTherapeuticsInc #News
Progressive Acceleration in Eledon Pharmaceuticals' Phase 1b and Phase 2 Studies Featuring Tegoprubart: A Focus on Kidney Transplant Patients and Organ Rejection Prevention: $ELDN As major… dlvr.it/T6drgQ #ELDN #kidneytransplant #eledon #competitors #ClinicalStudy
Advancements in Genetic Therapies Yield Promising Results in Treating Deafness and Genetic Disorders in Children: $REGN The field of pharmaceutical sciences has witnessed significant breakthroughs… dlvr.it/T6b94r #REGN #ClinicalStudy #MajorPharmaceuticalPreparations
Empowering Healing: COMP360 Psilocybin Shows Promise in Treating PTSD: $CMPS In a recent open-label phase 2 study, Compass Pathways plc announced positive top-line results regarding the safety… dlvr.it/T6b95M #CMPS #CompassPathwaysPlc #ClinicalStudy #competitors #News
Pioneering the Future of Endocrinological Therapies: Ascendis Pharma's TransCon PTH and TransCon hGH Show Promise in Addressing Chronic Hypoparathyroidism and Growth Hormone Deficiency: $ASND The… dlvr.it/T6fHVR #News #suppliers #AscendisPharmaA #ClinicalStudy #ASND
Pliant Therapeutics Boosts Bexotegrast Development in Idiopathic Pulmonary Fibrosis: $PLRX CSIMarket.com is excited to provide an update on the recent advancements made by Pliant Therapeutics… dlvr.it/T6W8q2 #News #ClinicalStudy #PliantTherapeuticsInc #PLRX
Vigil Neuroscience Achieves Milestone in ALS Treatment Trials: $VIGL Vigil Neuroscience, a leading biopharmaceutical company, recently announced its financial results for the first quarter of… dlvr.it/T6Z4N2 #VIGL #suppliers #ClinicalStudy #News #VigilNeuroscienceInc
Recent Advances in the Treatment and Understanding of Primary Biliary Cholangitis: A Comprehensive Overview of Key Findings from Digestive Disease Week 2024 Conference: $ICPT Primary… dlvr.it/T6fDDx #competitors #ClinicalStudy #InterceptPharmaceuticalsinc #News #ICPT
Revolutionizing Autoimmune Disease Management: The Promising Potential of FT522 CAR NK Cell Product Candidate: $FATE In a presentation at the recent American Society of Gene and Cell Therapy… dlvr.it/T6PF0W #FateTherapeuticsInc #FATE #ClinicalStudy #News #suppliers
Voyager Therapeutics Advances its TRACER-Generated Capsids and Tau Silencing Gene Therapy Program: Promising Preclinical Activity Signposting Towards Clinical Trials: $VYGR Voyager also presented… dlvr.it/T6b7bk #suppliers #News #ClinicalStudy #VoyagerTherapeuticsInc
MediciNova Lands Pivotal Patent for Extended-Release Formulations of Innovative Drug, MN-166 (Ibudilast): Poised to Reinvent the Pharmaceutical Landscape: $MNOV MediciNova, a soaring… dlvr.it/T6XSWv #MedicinovaInc #MajorPharmaceuticalPreparations #News #ClinicalStudy